Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-04T21:30:01.141Z Has data issue: false hasContentIssue false

Chapter 6 - Epilepsy and Intellectual Disability

from Section 2 - Co-morbidity

Published online by Cambridge University Press:  14 January 2019

By
Mike Kerr  and
Lance Watkins
Edited by
Mark Scheepers  and
Mike Kerr
Mark Scheepers
Affiliation:
2gether NHS Trust
Mike Kerr
Affiliation:
Cardiff University
Get access
Type
Chapter
Information
Seminars in the Psychiatry of Intellectual Disability , pp. 65 - 82
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Airaksinen, E. M., Matilainen, R., Mononen, T. et al. (2000) A population‐based study on epilepsy in mentally retarded children. Epilepsia, 41(9), 1214–20.Google Scholar
Alper, K., Schwartz, K. A., Kolts, R. L. & Khan, A. (2007) Seizure incidence in psychopharmacological clinical trials: An analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biological Psychiatry, 62(4), 345–54.Google Scholar
Andrews, T. M., Everitt, A. D. & Sander, J. W. A. S. (1999) A descriptive survey of long‐term residents with epilepsy and intellectual disability at the Chalfont Centre: Is there a relationship between maladaptive behaviour and magnetic resonance imaging findings? Journal of Intellectual Disability Research, 43(6), 475–83.Google Scholar
Arzimanoglou, A., French, J., Blume, W. T. et al. (2009) Lennox–Gastaut syndrome: A consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurology, 8(1), 82–93.Google Scholar
Bate, L. & Gardiner, M. (1999) Genetics of inherited epilepsies. Epileptic Disorders, 1(1), 7–19.Google Scholar
Beavis, J, Kerr, M., Marson, A. G., Dojcinov, I. (2007) Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database of Systematic Reviews, issue 3. art. no. CD005399.Google Scholar
Berg, A. T., Berkovic, S. F., Brodie, M. J. et al. (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia, 51(4), 676–85.CrossRefGoogle ScholarPubMed
Bowley, C. & Kerr, M. (2000) Epilepsy and intellectual disability. Journal of Intellectual Disability Research, 44(5), 529–43.Google Scholar
Boylan, L. S., Flint, L. A., Labovitz, D. L. et al. (2004) Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology, 62(2), 258–61.Google Scholar
Buchanan, N. (1996) The use of lamotrigine in juvenile myoclonic epilepsy. Seizure, 5(2), 149–51.Google Scholar
Camfield, C. & Camfield, P. (2008) Twenty years after childhood‐onset symptomatic generalized epilepsy the social outcome is usually dependency or death: A population‐based study. Developmental Medicine & Child Neurology, 50(11), 859–63.Google Scholar
Chadwick, D. (1994) Epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 57, 264–77.Google Scholar
Claes, L., Del-Favero, J., Ceulemans, B. et al. (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. American Journal of Human Genetics, 68(6), 1327–32.Google Scholar
Cockerell, O. C., Eckle, I., Goodridge, D. M., Sander, J. W. & Shorvon, S. D. (1995) Epilepsy in a population of 6000 re-examined: Secular trends in first attendance rates, prevalence, and prognosis. Journal of Neurology, Neurosurgery & Psychiatry, 58(5), 570–6.Google Scholar
Cooper, S. A., Smiley, E., Morrison, J., Williamson, A. & Allan, L. (2007) Mental ill-health in adults with intellectual disabilities: Prevalence and associated factors. British Journal of Psychiatry, 190(1), 27–35Google Scholar
Corbett, J. A., Harris, R., Robinson, R. et al. (1975) Epilepsy. In Mental Retardation and Developmental Disabilities (ed. Wortis, J.), vol. VII, pp. 79–111. Raven Press.Google Scholar
Crawford, P., Brown, S., Kerr, M. & Parke, Davis [clinical trials group] (2001) A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy. Seizure, 10(2), 107–15.Google Scholar
Curatolo, P., Bjørnvold, M., Dill, P. E. et al. (2016) The role of mTOR inhibitors in the treatment of patients with tuberous sclerosis complex: Evidence-based and expert opinions. Drugs, 76(5), 551–65.Google Scholar
Curatolo, P., Verdecchia, M. & Bombardieri, R. (2002) Tuberous sclerosis complex: A review of neurological aspects. European Journal of Paediatric Neurology, 6(1), 15–23.CrossRefGoogle ScholarPubMed
Devinsky, O., Hesdorffer, D. C., Thurman, D. J. Lhatoo, S. & Richerson, G. (2016) Sudden unexpected death in epilepsy: Epidemiology, mechanisms, and prevention. Lancet Neurology, 15(10), 1075–88.Google Scholar
Donat, J. F. & Wright, F. S. (1990) Episodic symptoms mistaken for seizures in the neurologically impaired child. Neurology, 40(1), 156–156.Google Scholar
Doran, Z., Shankar, R., Keezer, M. R. et al. (2016) Managing anti‐epileptic drug treatment in adult patients with intellectual disability: A serious conundrum. European Journal of Neurology, 23(7), 1152–7.Google Scholar
Dravet, C. (1978) Les epilepsies graves de l’enfant. Vie médicale., 8, 543–8.Google Scholar
Dravet, C. (2011) The core Dravet syndrome phenotype. Epilepsia, 52(s2), 3–9.CrossRefGoogle ScholarPubMed
Engel, J. (2001) A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia, 42(6), 796–803.Google Scholar
Englot, D. J., Chang, E. F. & Auguste, K. I. (2011) Vagus nerve stimulation for epilepsy: A meta-analysis of efficacy and predictors of response: A review. Journal of Neurosurgery, 115(6), 1248–55.Google Scholar
Espie, C. A., Watkins, J., Duncan, R. et al. (2001) Development and validation of the Glasgow Epilepsy Outcome Scale (GEOS): A new instrument for measuring concerns about epilepsy in people with mental retardation. Epilepsia, 42(8), 1043–51Google Scholar
Flores, L., Kemp, S., Colbeck, K. et al. (2012) Clinical experience with oral lacosamide as adjunctive therapy in adult patients with uncontrolled epilepsy: A multicentre study in epilepsy clinics in the United Kingdom (UK). Seizure, 21(7), 512–517.Google Scholar
Forsgren, L., Edvinsson, S. O., Hans, K., Heijbel, J. & Sidenvall, R. (1990) Epilepsy in a population of mentally retarded children and adults. Epilepsy Research, 6(3), 234–48.Google Scholar
Forsgren, L., Edvinsson, S. O., Nyström, L. & Blomquist, H. K. (1996) Influence of epilepsy on mortality in mental retardation: An epidemiologic study. Epilepsia, 37(10), 956–63.Google Scholar
Fryers, T. (1987) Epidemiological issues in mental retardation. Journal of Intellectual Disability Research, 31(4), 365–84.CrossRefGoogle ScholarPubMed
Gaily, E., Granström, M. L. & Liukkonen, E. (1998) Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. Journal of Intellectual Disability Research: JIDR, 42, 41–5.Google Scholar
Gauthier, A. C. & Mattson, R. H. (2015) Clobazam: A safe, efficacious, and newly rediscovered therapeutic for epilepsy. CNS Neuroscience & Therapeutics, 21(7), 543–8.Google Scholar
Glauser, T., Kluger, G., Sachdeo, R., Krauss, G., Perdomo, C. & Arroyo, S. (2008) Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome. Neurology, 70(21), 1950–8.Google Scholar
Grosso, S., Parisi, P., Spalice, A., Verrotti, A. & Balestri, P. (2014) Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy. European Journal of Paediatric Neurology, 18(1), 55–9.Google Scholar
Hancock, E. C. & Cross, H. J. (2009) Treatment of Lennox–Gastaut syndrome. Cochrane Database of Systematic Reviews, issue 3. art. no. CD003277.Google Scholar
Hanna, N. J., Black, M., Sander, J. W. et al. (2002) report of National Sentinel clinical audit into epilepsy-related death, Epilepsy – Death in the Shadows.Google Scholar
Hee Seo, J., Mock Lee, Y., Soo Lee, J., Chul Kang, H. & Dong Kim, H. (2007) Efficacy and tolerability of the ketogenic diet according to lipid: nonlipid ratios – Comparison of 3:1 with 4:1 diet. Epilepsia, 48(4), 801–5.CrossRefGoogle Scholar
Helmstaedter, C., Fritz, N. E., Kockelmann, E., Kosanetzky, N. & Elger, C. E. (2008) Positive and negative psychotropic effects of levetiracetam. Epilepsy & Behavior, 13(3), 535–41.Google Scholar
Heslop, P., Blair, P., Fleming, P., Hoghton, M., Marriott, A. & Russ, L. (2013) Confidential Enquiry into the Premature Deaths of people with Learning Disabilities (CIPOLD). University of Bristol: Norah Fry Research Centre, 10(1), 14.Google Scholar
Hitiris, N., Mohanraj, R., Norrie, J. & Brodie, M. J. (2007) Mortality in epilepsy. Epilepsy & Behavior, 10(3), 363–76.Google Scholar
Kahtan, S., Inman, C., Haines, A. & Holland, P. (1994) Teaching disability and rehabilitation to medical students. Medical Education, 28(5), 386–93.Google Scholar
Kelly, K., Stephen, L. J. & Brodie, M. J. (2004) Levetiracetam for people with mental retardation and refractory epilepsy. Epilepsy & Behavior, 5(6), 878–83.Google Scholar
Kerr, M. (1996) Epilepsy in patients with learning disability. Aspects of Epilepsy, 3(1), 6.Google Scholar
Kerr, M., Baker, G. A. & Brodie, M. J. (2005) A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: Impact on seizures, severity, and quality of life. Epilepsy & Behavior, 7(3), 472–80.Google Scholar
Kerr, M., Evans, S., Nolan, M. & Fraser, W. I. (1995) Assessing clinicians’ consultation with people with profound learning disability: Producing a rating scale. Journal of Intellectual Disability Research, 39(3), 187–90.Google Scholar
Kerr, M., Linehan, C., Brandt, C. et al. (2016) Behavioral disorder in people with an intellectual disability and epilepsy: A report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE. Epilepsia Open, 1(3–4), 102–11.Google Scholar
Kerr, M., Linehan, C., Thompson, R. et al. (2014) A White Paper on the medical and social needs of people with epilepsy and intellectual disability: The Task Force on Intellectual Disabilities and Epilepsy of the International League Against Epilepsy. Epilepsia, 55(12), 1902–6.Google Scholar
Kerr, M. P., Mensah, S., Besag, F. et al. (2011) International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia, 52(11), 2133–8.Google Scholar
Kerr, M., Scheepers, M., Besag, F. et al. [working group of the International Association of the Scientific Study of Intellectual Disability] (2001) Clinical guidelines for the management of epilepsy in adults with an intellectual disability. Seizure, 10(6), 401–9.Google Scholar
Kerr, M. P., Watkins, L. V., Angus-Leppan, H. et al. (2017) The provision of care to adults with an intellectual disability in the UK: A special report from the Intellectual Disability UK Chapter ILAE. ILAE.Google Scholar
Iinuma, K., Minami, T., Cho, K., Kajii, N. & Tachi, N. (1998) Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability. Journal of intellectual disability research: JIDR, 42, 68–73.Google Scholar
McDermott, S., Moran, R., Platt, T., Wood, H., Isaac, T. & Dasari, S. (2005) Prevalence of epilepsy in adults with mental retardation and related disabilities in primary care. American Journal on Mental Retardation, 110(1), 48–56.Google Scholar
McGrother, C. W., Bhaumik, S., Thorp, C. F., Hauck, A., Branford, D. & Watson, J. M. (2006) Epilepsy in adults with intellectual disabilities: Prevalence, associations and service implications. Seizure, 15(6), 376–86.CrossRefGoogle ScholarPubMed
McIntyre, J., Robertson, S., Norris, E. et al. (2005). Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: A randomised controlled trial. The Lancet, 366(9481), 205–10.Google Scholar
Mariani, E., Ferini-Strambi, L., Sala, M., Erminio, C. & Smirne, S. (1993) Epilepsy in institutionalized patients with encephalopathy: Clinical aspects and nosological considerations. American Journal on Mental Retardation, 98 (suppl.), 27–33.Google Scholar
Martin, K., Jackson, C. F., Levy, R. G. & Cooper, P. N. (2016) Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Systematic Reviews, issue 2, art. no. CD001903.Google Scholar
Matthews, T., Weston, N., Baxter, H., Felce, D. & Kerr, M. (2008) A general practice‐based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and carer stress. Journal of Intellectual Disability Research, 52(2), 163–73.Google Scholar
Mikati, M. A., Choueri, R., Khurana, D. S., Riviello, J., Helmers, S. & Holmes, G. (1998) Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability. Journal of Intellectual Disability Research: JIDR, 42, 57–62.Google Scholar
Morgan, C. L., Baxter, H. & Kerr, M. P. (2003) Prevalence of epilepsy and associated health service utilization and mortality among patients with intellectual disability. American Journal on Mental Retardation, 108(5), 293–300.Google Scholar
Morgan, V. A., Croft, M. L., Valuri, G. M. et al. (2012). Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depression. British Journal of Psychiatry, 200(4), 282–9.Google Scholar
Mula, M., Trimble, M. R. & Sander, J. W. (2004) Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. Seizure, 13(1), 55–7.Google Scholar
NICE (2012) Clinical Guideline 137: The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE.Google Scholar
Owen, M. J. (2014) New approaches to psychiatric diagnostic classification. Neuron, 84(3), 564–71.Google Scholar
Paul, A. (1997) Epilepsy or stereotypy? Diagnostic issues in learning disabilities. Seizure, 6(2), 111–20.Google Scholar
Petty, S. J., Paton, L. M., O’Brien, T. J. et al. (2005) Effect of antiepileptic medication on bone mineral measures. Neurology, 65(9), 1358–65.Google Scholar
Pueschel, S. M., Louis, S. & McKnight, P. (1991) Seizure disorders in Down syndrome. Archives of neurology, 48(3), 318–20.Google Scholar
Richardson, S. A., Koller, H., Katz, M. & McLaren, J. (1981) A functional classification of seizures and its distribution in a mentally retarded population. American Journal of Mental Deficiency, 85, 457–66.Google Scholar
Robertson, J., Hatton, C., Emerson, E. & Baines, S. (2015) Prevalence of epilepsy among people with intellectual disabilities: A systematic review. Seizure, 29, 46–62.Google Scholar
Rodway, C., Windfuhr, K., Kapur, N., Shaw, J. & Appleby, L. (2014) National Learning Disability Review Development Project Stage 1– Options Development Report. Manchester.Google Scholar
Sachdeo, R. C., Glauser, T. A., Ritter, F. O. et al. and Topiramate YL Study Group (1999) A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome. Neurology, 52(9), 1882–1882.Google Scholar
Sander, J. W. & Shorvon, S. D. (1987) Incidence and prevalence studies in epilepsy and their methodological problems: A review. Journal of Neurology, Neurosurgery & Psychiatry, 50(7), 829–39.Google Scholar
Saxena, A. & Sampson, J. R. (2015) Epilepsy in tuberous sclerosis: Phenotypes, mechanisms, and treatments. Seminars in Neurology, 35(3), 269–76.Google Scholar
Shah, E., Reuber, M., Goulding, P., Flynn, C., Delanty, N. & Kemp, S. (2016) Clinical experience with adjunctive perampanel in adult patients with uncontrolled epilepsy: A UK and Ireland multicentre study. Seizure, 34, 1–5.Google Scholar
Shankar, R., Cox, D., Jalihal, V., Brown, S., Hanna, J. & Mclean, B. (2013) Sudden unexpected death in epilepsy (SUDEP): Development of a safety checklist. Seizure, 22(10), 812–17.Google Scholar
Shepherd, C. & Hosking, G. (1989) Epilepsy in school children with intellectual impairments in Sheffield: The size and nature of the problem and the implications for service provision. Journal of Intellectual Disability Research, 33(6), 511–14.Google Scholar
Smith, D., Chadwick, D., Baker, G., Davis, G. & Dewey, M. (1993) Seizure severity and the quality of life. Epilepsia, 34(s5), s31–s35.Google Scholar
Stafstrom, C. E. (1993) Epilepsy in Down syndrome: Clinical aspects and possible mechanisms. American Journal on mental retardation, 98 (suppl.), 12–26.Google Scholar
Steffenburg, U., Hagberg, G. & Kyllerman, M. (1995). Active epilepsy in mentally retarded children. II. Etiology and reduced pre- and perinatal optimality. Acta Paediatrica, 84(10), 1153–9.Google Scholar
Tellez‐Zenteno, J. F., Patten, S. B., Jetté, N., Williams, J. & Wiebe, S. (2007) Psychiatric comorbidity in epilepsy: A population‐based analysis. Epilepsia, 48(12), 2336–44.Google Scholar
Trevathan, E., Motte, J., Arvidsson, J., Manasco, P. & Mullens, L. (1996) Safety and tolerability of adjunctive Lamictal for the treatment of the Lennox–Gastaut syndrome: Results of multinational, double blind, placebo-controlled trial. Epilepsia, 37(suppl. 5), s202.Google Scholar
Trollor, J. N., Ruffell, B., Tracy, J. et al. (2016) Intellectual disability health content within medical curriculum: An audit of what our future doctors are taught. BMC Medical Education, 16(1), 1–9.Google ScholarPubMed
Turky, A., Felce, D., Jones, G. & Kerr, M. (2011) A prospective case control study of psychiatric disorders in adults with epilepsy and intellectual disability. Epilepsia, 52(7), 1223–30.Google Scholar
Wagemans, A. M. A., Fiolet, J. F. B. M., Van Der Linden, E. S. & Menheere, P. P. C. A. (1998) Osteoporosis and intellectual disability: Is there any relation? Journal of Intellectual Disability Research, 42(5), 370–4.Google Scholar
Webb, D. W., Fryer, A. E. & Osborne, J. P. (1991) On the incidence of fits and mental retardation in tuberous sclerosis. Journal of Medical Genetics, 28(6), 395–7.Google Scholar
Welsh Office (1995) Welsh Health Survey. Welsh Office.Google Scholar
Wiebe, S., Blume, W. T., Girvin, J. P. & Eliasziw, M. (2001) A randomized, controlled trial of surgery for temporal-lobe epilepsy. New England Journal of Medicine, 345(5), 311–18.CrossRefGoogle ScholarPubMed
Wilson, S. J., Saling, M. M., Lawrence, J. & Bladin, P. F. (1999) Outcome of temporal lobectomy: Expectations and the prediction of perceived success. Epilepsy Research, 36(1), 1–14.Google Scholar
Wolff, M., Cassé‐Perrot, C. & Dravet, C. (2006) Severe myoclonic epilepsy of infants (Dravet syndrome): Natural history and neuropsychological findings. Epilepsia, 47(s2), 45–8.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×